81 matches.
- Breaking Down the Shifting Vaccine Policy Landscape
- Aligning Business Goals with Legal Strategies Amid Regulatory Change
- Executive Actions Impact Federally Funded Research: What Institutions Should Do Now
- Criminal Health Care Fraud Enforcement: Projections for 2025 and Beyond
- 2025 Outlook: The Department of Health and Human Services Under the Second Trump Administration
- Health Policy Update: Impact of the 2024 U.S. Elections
- Advancements of Artificial Intelligence in Health Care – One Year After White House Executive Order
- New State Legislation Increases Oversight of Health Care Transactions
- New HIPAA Final Rule: Key Changes to Reproductive Health Care Privacy
- Workplace Violence in Health Care: Dissecting the Legal Landscape and Implications for Employers
- Navigating the Labyrinth of Private Equity Investments in Health Care
- The DEA Is Knocking at Your Door . . . Are You Prepared?
- The Future of Laboratory Testing Just Got a Little Clearer: FDA's Final Rule on LDTs
- Down Goes Chevron: A 40-Year Precedent Overturned by the Supreme Court
- Unveiling Gender-Affirming Care: Why It Matters and What’s at Stake
- FDA Releases Laboratory-Developed Tests Final Rule
- Spilling Secrets: Navigating Physician Non-Compete Litigation
- 50-State Noncompete Survey for Health Care Employers
- Key Changes in Finalized Antitrust Merger Guidelines
- Spilling Secrets: Latest Developments – Restrictive Covenants in the Health Care Industry
- Antitrust Updates: Changes Affecting Merger Review and Enforcement in 2024 and Beyond
- Direct Access Laboratory Testing: Future FDA Proposed Regulations on LDTs
- Epstein Becker Green Expands into Pacific Northwest with Six-Attorney Health Care Team in Portland
- Post-Dobbs: One Year Later
- Managing Trade Secrets and Restrictive Covenants in Health Care M&A Deals
- Spilling Secrets: How to Secure Key Employees in Health Care M&A Transactions
- Inflation Reduction Act’s Drug Price Negotiation Provisions – What’s Next?
- Direct Access Laboratory Testing: Physician Orders and Specimen Collection
- 2023 Deal Cycle: Considerations for Transactions in Uncertain Economic Times
- The End of the Public Health Emergency – What’s to Come?
- Direct Access Laboratory Testing: Reimbursement & Compliance
- Direct Access Laboratory Testing: Navigating the Regulatory Landscape
- The PACE Program: What Changes May Be Coming Soon?
- Post-Dobbs: Considerations for Clinical Trials and Research
- 2023 Health Policy Outlook
- Post-Dobbs: Navigating the Fast-Changing and Uncertain Legal Landscape
- Health Care's Past, Present, and Future
- Hot Areas in COVID-19 Enforcement, Testing, and Funding
- Interoperability: Information Blocking Claims and Enforcement
- Interoperability: Health Care's Next Disruptor Is openEHR
- Interoperability: A New Vision Through openEHR
- OSHA's Permanent COVID-19 Standard and Enforcement Blitz
- Entrepreneurship in Biotech: Growing Your Business
- DOJ Goes After Civil Cyber-Fraud
- Interoperability: The Role of Health Information Exchanges
- Record-Shattering Year for FCA Recoveries in Health Care
- Interoperability: The Provider Perspective
- Chevron Deference: Is It Time for Change?
- No Surprises Act: New Rules and Guidance for Stakeholders (Part 2)
- No Surprises Act: New Rules and Guidance for Stakeholders (Part 1)
- Getting Ready for the No Surprises Act
- How Will Biden’s Executive Order Impact Future Hospital Mergers?
- CMS Vaccine Rule for Health Care Workers
- What Is the Future of the Acute Care Hospital Industry?
- No Surprises Act: Considerations for Plans and Providers
- Career Pathways: Welcome to Epstein Becker Green – Columbus Ohio Team
- How Can Companies in the Health Care and Life Sciences Industries Strengthen Their Cybersecurity Posture?
- Federal and State Cannabis Rules Are Moving in Different Directions
- Are Vaccine Passports the Key to Reopening?
- Whistleblowing, Retaliation Risks Are On the Rise for Health Care Employers
- CMS and OIG Final Rules for Innovating Your Value-Based Payment Program
- American Rescue Plan Delivers New Stimulus Funding
- COVID-19 Vaccines: The Ethical and Legal Challenges to Immunization
- Congressional Health Care Legislative Agenda
- Private Equity Investment in Risk-Bearing Provider Organizations
- The Biden Administration's First 100 Days
- SCOTUS Watch: The ACA and Key Health Law Areas Justice Barrett Could Impact
- On the Ballot 2020: Health Care Policy Outlook
- Fraud and Abuse Enforcement Priorities in the Wake of COVID-19
- The Impact of Revenue and Budget Shortfalls in Light of Coronavirus
- Coronavirus Balancing Act, Vaccination Requirements, #MeToo
- Health Care Continues to Drive False Claims Act Recoveries: Thought Leaders in Health Law Video Series
- Employment Concerns in Health Care M&A: Thought Leaders in Health Law Video Series
- Trends in Transactional Due Diligence: Thought Leaders in Health Law Video Series
- Trends in Medicaid Disruption: Thought Leaders in Health Law Video Series
- Trends in TRICARE: Thought Leaders in Health Law Video Series
- Trends in Antitrust: Thought Leaders in Health Law Video Series
- Employment Law This Week®: NLRB's "Quickie Election" Rules, Layoff Doesn't Violate FMLA, Plans Exempt from ERISA, Amended "Persuader Rule"
- Trends in Individual Accountability in Health Care Fraud Enforcement: Thought Leaders in Health Law Video Series
- Health Care Trends and Policies Impacted by the 2016 Elections: Thought Leaders in Health Law Video Series
- Trends and Innovations in Value-Based Payment: Thought Leaders in Health Law Video Series